DermTech Inc (NAS:DMTK)
$ 0.638 0.018 (2.9%) Market Cap: 22.31 Mil Enterprise Value: 20.21 Mil PE Ratio: 0 PB Ratio: 0.37 GF Score: 44/100

DermTech Inc Dermatology Summit 2021 Transcript

Dec 29, 2020 / NTS GMT
Release Date Price: $28.01 (+10.36%)
Michael Howell
DermTech, Inc. - Chief Scientific Officer

Thank you to the organizers for the opportunity to present our novel non-invasive Smart Sticker technology and the DermTech approach to precision dermatology. As a brief introduction, DermTech is located in La Jolla, California, and has a CLIA-approved laboratory for the processing and commercial analysis of the Smart Sticker.

DermTech additionally holds broad patents on the isolation of genomic and proteomic material from the Smart Sticker. In 2015, DermTech launched an approved diagnostic test for the identification of melanoma, which we will discuss in a few slides. Finally, DermTech has a growing pipeline of products, partnerships, and collaborations leveraging the non-invasive Smart Sticker for skin cancers and inflammatory skin diseases.

On the left side of your screen is an actual Smart Sticker following the non-invasive collection of a skin sample. Once collected, you can clearly see the layer of keratinocytes attached to the Smart Sticker. Due to the biological nature of skin, keratinocytes containing genomic and proteomic

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot